A Pharmacoeconomic Analysis of In-Hospital Costs Resulting from Reintubation in Preterm Infants Treated with Lucinactant, Beractant, or Poractant Alfa

OBJECTIVES: Reintubation and subsequent mechanical ventilation (MV) in preterm infants after surfactant replacement therapy are associated with excess morbidity and mortality and likely increase in-hospital costs. Specific surfactant therapy selection for prevention of respiratory distress syndrome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Guardia, Carlos G., Moya, Fernando R., Sinha, Sunil, Simmons, Phillip D., Segal, Robert, Greenspan, Jay S.
Formato: Artigo
Idioma:Inglês
Publicado em: Pediatric Pharmacy Advocacy Group 2012
Assuntos:
Clinical Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3526925/
https://ncbi.nlm.nih.gov/pubmed/23258964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-17.3.220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados